Heribert Juergens
University Hospital Münster(DE)
Publications by Year
Research Areas
Sarcoma Diagnosis and Treatment, Lymphoma Diagnosis and Treatment, CAR-T cell therapy research, Cardiac tumors and thrombi, Immune Cell Function and Interaction
Most-Cited Works
- → Osteosarcoma treatment – Where do we stand? A state of the art review(2013)1,258 cited
- → Ewing Sarcoma: Current Management and Future Approaches Through Collaboration(2015)716 cited
- → R1507, a Monoclonal Antibody to the Insulin-Like Growth Factor 1 Receptor, in Patients With Recurrent or Refractory Ewing Sarcoma Family of Tumors: Results of a Phase II Sarcoma Alliance for Research Through Collaboration Study(2011)318 cited
- → Preliminary Efficacy of the Anti-Insulin–Like Growth Factor Type 1 Receptor Antibody Figitumumab in Patients With Refractory Ewing Sarcoma(2011)210 cited
- → 2B4 (CD244) Signaling by Recombinant Antigen-specific Chimeric Receptors Costimulates Natural Killer Cell Activation to Leukemia and Neuroblastoma Cells(2009)201 cited
- → Cooperative Trial CWS-91 for Localized Soft Tissue Sarcoma in Children, Adolescents, and Young Adults(2009)177 cited
- → Cyclophosphamide Compared With Ifosfamide in Consolidation Treatment of Standard-Risk Ewing Sarcoma: Results of the Randomized Noninferiority Euro-EWING99-R1 Trial(2014)168 cited
- → The value of local treatment in patients with primary, disseminated, multifocal Ewing sarcoma (PDMES)(2009)168 cited
- → High-Dose Chemotherapy and Blood Autologous Stem-Cell Rescue Compared With Standard Chemotherapy in Localized High-Risk Ewing Sarcoma: Results of Euro-E.W.I.N.G.99 and Ewing-2008(2018)160 cited
- → The ganglioside antigen GD2 is surface-expressed in Ewing sarcoma and allows for MHC-independent immune targeting(2012)141 cited